Literature DB >> 27379957

Pre-Training Muscle Characteristics of Subjects Who Are Obese Determine How Well Exercise Training Will Improve Their Insulin Responsiveness.

Charles A Stuart1, Michelle L Lee, Mark A South, Mary E A Howell, Brian M Cartwright, Michael W Ramsey, Michael H Stone.   

Abstract

Stuart, CA, Lee, ML, South, MA, Howell, MEA, Cartwright, BM, Ramsey, MW, and Stone, MH. Pre-training muscle characteristics of subjects who are obese determine how well exercise training will improve their insulin responsiveness. J Strength Cond Res 31(3): 798-808, 2017-Only half of prediabetic subjects who are obese who underwent exercise training without weight loss increased their insulin responsiveness. We hypothesized that those who improved their insulin responsiveness might have pretraining characteristics favoring a positive response to exercise training. Thirty nondiabetic subjects who were obese volunteered for 8 weeks of either strength training or endurance training. During training, subjects increased their caloric intake to prevent weight loss. Insulin responsiveness by euglycemic clamps and muscle fiber composition, and expression of muscle key biochemical pathways were quantified. Positive responders initially had 52% higher intermediate muscle fibers (fiber type IIa) with 27% lower slow-twitch fibers (type I) and 23% lower expression of muscle insulin receptors. Whether after weight training or stationary bike training, positive responders' fiber type shifted away from type I and type IIa fibers to an increased proportion of type IIx fibers (fast twitch). Muscle insulin receptor expression and glucose transporter type 4 (GLUT4) expression increased in all trained subjects, but these moderate changes did not consistently translate to improvement in whole-body insulin responsiveness. Exercise training of previously sedentary subjects who are obese can result in muscle remodeling and increased expression of key elements of the insulin pathway, but in the absence of weight loss, insulin sensitivity improvement was modest and limited to about half of the participants. Our data suggest rather than responders being more fit, they may have been less fit, only catching up to the other half of subjects who are obese whose insulin responsiveness did not increase beyond their pretraining baseline.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27379957      PMCID: PMC5195912          DOI: 10.1519/JSC.0000000000001530

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   3.775


  33 in total

1.  Genomic predictors of trainability.

Authors:  Claude Bouchard
Journal:  Exp Physiol       Date:  2011-10-03       Impact factor: 2.969

2.  Insulin sensitivity by oral glucose minimal models: validation against clamp.

Authors:  Chiara Dalla Man; Kevin E Yarasheski; Andrea Caumo; Heather Robertson; Gianna Toffolo; Kenneth S Polonsky; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-07-12       Impact factor: 4.310

3.  Enzyme activity and fiber composition in skeletal muscle of untrained and trained men.

Authors:  P D Gollnick; R B Armstrong; C W Saubert; K Piehl; B Saltin
Journal:  J Appl Physiol       Date:  1972-09       Impact factor: 3.531

4.  Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT).

Authors:  Lori A Bateman; Cris A Slentz; Leslie H Willis; A Tamlyn Shields; Lucy W Piner; Connie W Bales; Joseph A Houmard; William E Kraus
Journal:  Am J Cardiol       Date:  2011-07-07       Impact factor: 2.778

Review 5.  PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.

Authors:  Vitor A Lira; Carley R Benton; Zhen Yan; Arend Bonen
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-04-06       Impact factor: 4.310

Review 6.  The role of weight loss and exercise in correcting skeletal muscle mitochondrial abnormalities in obesity, diabetes and aging.

Authors:  Frederico G S Toledo; Bret H Goodpaster
Journal:  Mol Cell Endocrinol       Date:  2013-06-20       Impact factor: 4.102

Review 7.  Advances in exercise, fitness, and performance genomics in 2011.

Authors:  Stephen M Roth; Tuomo Rankinen; James M Hagberg; Ruth J F Loos; Louis Pérusse; Mark A Sarzynski; Bernd Wolfarth; Claude Bouchard
Journal:  Med Sci Sports Exerc       Date:  2012-05       Impact factor: 5.411

8.  Effects of aerobic training, resistance training, or both on glycemic control in type 2 diabetes: a randomized trial.

Authors:  Ronald J Sigal; Glen P Kenny; Normand G Boulé; George A Wells; Denis Prud'homme; Michelle Fortier; Robert D Reid; Heather Tulloch; Douglas Coyle; Penny Phillips; Alison Jennings; James Jaffey
Journal:  Ann Intern Med       Date:  2007-09-18       Impact factor: 25.391

9.  Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial.

Authors:  M Bouchonville; R Armamento-Villareal; K Shah; N Napoli; D R Sinacore; C Qualls; D T Villareal
Journal:  Int J Obes (Lond)       Date:  2013-07-04       Impact factor: 5.095

10.  Energy cost of resistance exercises: an uptade.

Authors:  Victor M Reis; Roberto S Júnior; Adam Zajac; Diogo R Oliveira
Journal:  J Hum Kinet       Date:  2011-10-04       Impact factor: 2.193

View more
  2 in total

1.  Muscle hypertrophy in prediabetic men after 16 wk of resistance training.

Authors:  Charles A Stuart; Michelle L Lee; Mark A South; Mary E A Howell; Michael H Stone
Journal:  J Appl Physiol (1985)       Date:  2017-06-29

2.  High-Intensity Interval Training Is Equivalent to Moderate-Intensity Continuous Training for Short- and Medium-Term Outcomes of Glucose Control, Cardiometabolic Risk, and Microvascular Complication Markers in Men With Type 2 Diabetes.

Authors:  Shohn G Wormgoor; Lance C Dalleck; Caryn Zinn; Robert Borotkanics; Nigel K Harris
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.